Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cannabix Technologies ( (TSE:BLO) ) has issued an announcement.
Cannabix Technologies has secured its first international distributor order for its BreathLogix autonomous alcohol screening devices and accessories from its exclusive Australian partner, Breathalyser Sales & Service Pty Ltd, covering Australia, New Zealand and the Pacific Islands. The BreathLogix system offers rapid pre-access breath alcohol checks, identity-confirming photos, real-time alerts and cloud-based reporting, and can be integrated with site access controls and fleet management systems, positioning it for deployment across industries such as mining, oil and gas, industrial and logistics. Featuring a patent-pending pre-calibrated sensor cartridge to simplify maintenance, the product launch momentum has prompted Cannabix to cancel a planned non-brokered private placement and reassess its near-term capital needs in early 2026, while the company also initiates a short investor awareness campaign to broaden market visibility.
The most recent analyst rating on (TSE:BLO) stock is a Hold with a C$0.59 price target. To see the full list of analyst forecasts on Cannabix Technologies stock, see the TSE:BLO Stock Forecast page.
Spark’s Take on TSE:BLO Stock
According to Spark, TipRanks’ AI Analyst, TSE:BLO is a Neutral.
The score is held down primarily by very weak financial performance (minimal revenue, widening losses, and sustained cash burn with shrinking equity). Offsetting factors include improving technical momentum (price above major moving averages with positive MACD) and positive corporate progress (regulatory milestone, patent award, and repeat orders), though valuation remains challenged due to negative earnings.
To see Spark’s full report on TSE:BLO stock, click here.
More about Cannabix Technologies
Cannabix Technologies Inc. is a Canadian technology company that develops marijuana and alcohol breath-testing technologies for use in workplaces, law enforcement and other safety-sensitive environments. Its product portfolio includes autonomous, unmanned breathalyzer systems such as the BreathLogix platform, designed to provide rapid, integrated screening solutions for employers across industrial, transportation and other high-risk sectors.
Average Trading Volume: 34,098
Technical Sentiment Signal: Buy
Current Market Cap: C$70.22M
See more data about BLO stock on TipRanks’ Stock Analysis page.